SCHEMBL7824872

SCHEMBL7824872

Cc1ccc2[nH]cc(C3=C(c4cn(CCCN(C)C)c5ccc(C)cc45)C(=O)NC3=O)c2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 7/20 0.71
PRKACG P22612 7/20 0.71
PRKACB P22694 7/20 0.71
PRKCA P17252 6/20 0.71
PRKCB P05771 5/20 0.71
GSK3B P49841 5/20 0.71
PRKCE Q02156 4/20 0.71
PRKCH P24723 3/20 0.71
PRKCQ Q04759 3/20 0.71
PRKCD Q05655 3/20 0.71
CDK4 P11802 3/20 0.71
CCND1 P24385 3/20 0.71
CCNB2 O95067 3/20 0.71
CDK1 P06493 3/20 0.71
CCNB1 P14635 3/20 0.71
CCNB3 Q8WWL7 3/20 0.71
PRKD1 Q15139 2/20 0.71
TDP1 Q9NUW8 2/20 0.71
PIM1 P11309 2/20 0.71
MEN1 O00255 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9087075 0.94 PRKACA (0.62) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL9087076 0.93 PRKACA (0.82) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL9087104 0.90 GSK3B (0.58) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL9087610 0.89 PRKACA (0.69) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL7826910 0.89 GSK3B (0.69) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL9085708 0.89 PRKACA (0.69) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL7824942 0.89 PRKACA (0.69) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL7814913 0.89 PRKACA (0.69) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL9085100 0.89 PRKACA (0.69) PRKACAPRKACGPRKACBPRKCAPRKCB
SCHEMBL9088390 0.88 CAMK2D (0.68) PRKACAPRKACGPRKACBPRKCAPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP claimed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US claimed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP claimed
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP disclosed
US-5516915-A Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US disclosed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP disclosed